Daniel Zips
German Cancer Research Center
45 Papers
164 Citations
Daniel Zips is an academic researcher from German Cancer Research Center. The author has contributed to research in topics: Radiation therapy & Cancer. The author has an hindex of 10, co-authored 45 publications. Previous affiliations of Daniel Zips include Helmholtz-Zentrum Dresden-Rossendorf.
Chat about Author
Papers
Radiolabeled anti-EGFR-antibody improves local tumor control after external beam radiotherapy and offers theragnostic potential.
Lydia Koi,Ralf Bergmann,Kerstin Brüchner,Jens Pietzsch,Hans-Jürgen Pietzsch,Hans-Jürgen Pietzsch,Mechthild Krause,Jörg Steinbach,Jörg Steinbach,Daniel Zips,Michael Baumann +10 more
TL;DR: PET imaging of bioavailability of labeled cetuximab appears to be a suitable predictor for response to EBRIT, and this theragnostic approach should be further explored for clinical translation.
51
Two or four hour [18F]FMISO-PET in HNSCC
Nasreddin Abolmaali,Robert Haase,A. Koch,Daniel Zips,Jörg Steinbach,Michael H. Baumann,Joerg Kotzerke,K. Zöphel +7 more
TL;DR: Data acquisition of [18F]FMISO should be done 4 h p.i. to gather the optimal contrast, preferably allowing further analysis, e.
42
First experience of autonomous, un-supervised treatment planning integrated in adaptive MR-guided radiotherapy and delivered to a patient with prostate cancer
Luise A. Künzel,M. Nachbar,Markus Hagmüller,Cihan Gani,S. Boeke,Daniel Zips,Daniela Thorwarth +6 more
TL;DR: An autonomous un-supervised treatment planning approach, integrated as basis for online adaptive magnetic resonance guided RT (MRgRT), which was delivered to a prostate cancer patient as a first-in-human experience and may allow for real-time MRgRT applications in the future.
27
Simultaneous Targeting of RSK and AKT Efficiently Inhibits YB-1-Mediated Repair of Ionizing Radiation-Induced DNA Double-Strand Breaks in Breast Cancer Cells.
TL;DR: Simultaneous targeting of RSK and AKT might be an efficient approach to block the repair of DSBs after irradiation and to induce radiosensitization of breast cancer cells.
24
Prognostic parameters and outcome after re-irradiation for progressive glioblastoma.
Kerstin Zwirner,Frank Paulsen,J. Schittenhelm,C. Borchers,M. Skardelly,Daniel Zips,Franziska Eckert +6 more
TL;DR: In this article, the authors analyzed outcome and prognostic parameters of patients with re-irradiated glioblastoma treated at the same institution since 1998, and found that patients who were re-rradiated with single-dose stereotactic radiosurgery or hypofractionated regimes showed a superior overall survival after primary diagnosis compared to norm-of-ractionated treatment.
19